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E-mail address: zouguolin@whu.edu.cn (G. Zou).Here, we show that during in vivo folding of the precursor, the propeptide of subtilisin nattokinase
functions as an intramolecular chaperone (IMC) that organises the in vivo folding of the subtilisin
domain. Two residues belonging to b-strands formed by conserved regions of the IMC are crucial
for the folding of the subtilisin domain through direct interactions. An identical protease can fold
into different conformations in vivo due to the action of a mutated IMC, resulting in different
kinetic parameters. Some interfacial changes involving conserved regions, even those induced by
the subtilisin domain, blocked subtilisin folding and altered its conformation. Insight into the inter-
action between the subtilisin and IMC domains is provided by a three-dimensional structural model.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Proteases are ubiquitous enzymes that are crucial for cell
growth, development, apoptosis, protein turnover, and cell cycle
regulation during life process [1]. The basis of these functions is
the unique correct three-dimensional structures of the proteins,
and all of the information necessary for proteolysis is encoded by
the protease’s amino-acid sequence [2]. Diseases such as cystic
ﬁbrosis, Alzheimer’s disease, bovine spongiform encephalopathy,
and even some forms of cancer are believed to result of defective
protein folding [3]. The proper folding of some proteases requires
the assistance of other proteins called molecular chaperones, while
the folding of other proteases requires an intramolecular chaper-
one (IMC) [4]. There have been several IMC-mediated protein
folding mechanisms identiﬁed for numerous prokaryotic and
eukaryotic proteases, including subtilisin E [5], a-lytic protease
[6], aqualysin I [7], carboxypeptidase Y [8], cathepsin L [9] and
thermolysin [10]. As demonstrated by our earlier studies [11–13],chemical Societies. Published by E
T, wild-type; NK, subtilisin
lis constant; MD, molecular
succinyl-Ala-Ala-Pro-Phe-p-the folding of subtilisin nattokinase (NK) is guided by an IMC,
the 77-residue propeptide at the N-terminal end of the subtilisin.
We have previously used site-directed mutagenesis and molec-
ular dynamic simulations to probe the importance of hydrogen
bonds in the active site of NK, and we constructed a three-dimen-
sional model of NK [11,12]. In addition, our previous study demon-
strated that active NK was not detected without the assistance of
the propeptide [13]. This observation raised the question of
whether the propeptide acts as an IMC, guiding the in vivo folding
of NK. Inouye and co-workers has reported on the in vitro refolding
pathway of subtilisin E [5]. Experiments in vitro allow the real-
time monitoring of the kinetics of the various stages that result
in maturation. However, some results concerning subtilisin BPN0
by Wells and co-workers have demonstrated that some structural,
enzymatic, or cofactor function is missing during in vitro refolding,
and the mechanism of the IMC is not consistent with that of
subtilisin E [14]. The propeptide guides the refolding of denatured
subtilisin in vitro, but it is unclear whether the propeptide acts as
an IMC during in vivo maturation of the precursor. It is also not
known which amino acids play essential roles in this process.
In this study, we investigated the in vivo and in vitro processing
of the precursor. Active wild-type (WT) subtilisin and several
mutants were produced in vivo by our method. For other mutants,
active subtilisin was no longer produced. These mutants were
processed using a rapid-dilution folding technique to refold thelsevier B.V. All rights reserved.
Table 1
Kinetic constants of WT subtilisin, Ile11Val, Ile30Val, Gly34Asp, Trp106Tyr and
Trp113Tyr mutants for the hydrolysis of succinyl-Ala-Ala-Pro-Phe-p-nitroanilide.
Enzymes kcat (s1) Km (lm) kcat/Km (s1 mM1)
WT 9.15 (±0.6) 161 (±7.9) 56.8
Ile11Val 3.08 (±0.5) 183 (±5.4) 16.8
Ile30Val 9.14 (±0.6) 164 (±6.6) 55.8
Gly34Asp 0.64 (±0.2) 197 (±8.0) 3.23
Trp106Tyr 1.98 (±0.5) 87 (±6.1) 22.7
Trp113Tyr 3.71 (±0.4) 129 (±6.4) 28.7
Assays were measured with the chromogenic substrate suc-AAPF-pNA in 10 mM
phosphate buffer, pH 8.0, 4% (v/v) DMSO at (25 ± 0.2) C.
4790 Y. Jia et al. / FEBS Letters 584 (2010) 4789–4796protein in vitro. Simultaneously, sequence alignments, homology
modelling and molecular dynamics (MD) simulations were com-
pleted to provide the insight into the interaction between the
IMC and subtilisin domains.
2. Materials and methods
2.1. Materials
Bacillus subtilis var. natto strain AS 1.107 was purchased from
the Institute of Microbiology, Chinese Academy of Sciences
(Beijing, China). All of the restriction enzymes used were from
Takara Shuzo Co. Ltd. Escherichia coli BL21 (DE3) cells, which were
used as the host cells, and the vector pET-26b (+) were from
Novagen. The Ni-NTA column was from Invitrogen, and the DEAE
Sepharose Fast Flow column was from Amersham Biosciences.
The BCA protein assay reagent kit was from Pierce. The substrate
succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (suc-AAPF-pNA) were
purchased from Sigma (St. Louis, MO, USA). Mouse anti-His-tag
monoclonal antibody and HRP-goat anti-mouse IgG (H + L) were
from Genscript. Polyvinylidene diﬂuoride (PVDF) and enhanced
chemiluminescence Western Blotting Detection Reagents were
from Millipore Corporation.
2.2. Construction of WT NK and mutants
B. subtilis var. natto was used as the source of genomic DNA.
E. coli BL21 (DE3) was the host bacterial strain for the pET-26b
(+) vector expression system. The gene encoding the precursor
NK was inserted into the plasmid pET-26b (+), and mutations were
introduced by site-directed mutagenesis [15].
2.3. Expression and puriﬁcation
The recombinant plasmids were used to transform the T7 expres-
sion host strain BL21 (DE3) [16]. Protein expression was induced by
adding isopropyl-1-thio-b-D-galactopyranoside (IPTG) (ﬁnal concen-
tration, 0.7 mM). After cultivation, the cells were harvested by centri-
fugation and washed twice with a wash buffer containing 50 mM
NaH2PO4 and 300 mM NaCl, pH 8.0. The cells were resuspended in
wash buffer and then disrupted by sonication on ice. The lysate was
centrifuged, and the supernatant and pellet were separated. For WT
subtilisin and the Ile11Val, Ile30Val andGly34Aspmutants, the super-
natantwasapplied to anNi-NTAcolumnand to aDEAESepharose Fast
Flow column. For the Ser221Ala, Trp106Tyr and Trp113Tyr mutants,
the pelletwaswashed bywash buffer twice and dissolved in 6 Mgua-
nidine hydrochloride. After centrifugation, the denatured proteins in
the supernatant were refolded by rapid dilution for 24 h, and then
the proteins were applied to an Ni-NTA column. After puriﬁcation to
homogeneity, the protein concentration was determined using a
BCA protein assay reagent kit.
2.4. SDS–PAGE and Western blotting
Sodium dodecyl sulphate–polyacrylamide gel electrophoresis
(SDS–PAGE) was performed on a 12% (w/v) polyacrylamide sepa-
rating gel with a 5% (w/v) stacking layer according to the procedure
of Laemmli [17].
For immunoblotting, the proteins separated by SDS–PAGE were
electrically transferred onto a polyvinylidene diﬂuoride mem-
brane. The membrane was soaked in blocking buffer (5% non-fat
dry milk) overnight at 4 C and then incubated with mouse
anti-His-tag monoclonal antibody at 37 C for 1.5 h, followed by
HRP-goat anti-mouse IgG (H + L) at 37 C for 45 min. Detection
was performed using enhanced chemiluminescence Western Blot-
ting Detection Reagents.2.5. Circular dichroism studies
Circular dichroism (CD) spectra were measured on a JASCO
J-810 automatic spectropolarimeter (Jasco, Tokyo, Japan). The
concentration of puriﬁed proteins was maintained at 100 lg/ml.
All spectral measurements were performed in 10 mM phosphate
buffer, pH 7.0, and scans were carried out between wavelengths
of 260 and 190 nm.
2.6. Fluorescence studies
Fluorescence studies were carried out on an F-4500 ﬂuores-
cence spectrometer (Hitachi, Japan). In the intrinsic ﬂuorescence
experiments, the puriﬁed proteins (10 lg/ml) were excited at
295 nm, and the emission scans were recorded from 300 to
500 nm.
2.7. Rapid-dilution folding technique
Folding was initiated by rapid dilution of one volume of dena-
tured protein in 6 M guanidine hydrochloride, pH 4.8, into 14 vol-
umes of refolding buffer (50 mM MES–NaOH (pH 6.5), containing
0.5 M (NH4)2SO4, and 1 mM CaCl2), at 25 C. To terminate the fold-
ing reaction, 350-ll aliquots were removed at ﬁxed time intervals
and treated with an equal volume of 40% trichloroacetic acid. The
precipitated proteins were collected by centrifugation, washed
with cold 100% acetone, and dissolved in SDS–PAGE sample buffer
[17].
2.8. Determination of kinetic parameters
Kinetic parameters were measured using the chromogenic sub-
strate suc-AAPF-pNA in 10 mM phosphate buffer, pH 8.0, 4% (v/v)
DMSO at (25 ± 0.2) C [18]. The absorbance of the p-nitroaniline
produced during the incubation was measured at 405 nm. Enzyme
concentrations were determined to permit calculation of the turn-
over number (kcat) from the relationship kcat = Vmax/[enzyme]. The
Michaelis constant (Km) and Vmax values were determined from the
initial rate measurements for the hydrolysis of suc-AAPF-pNA. All
of these kinetic parameters are shown in Table 1.
2.9. Homology modelling and MD simulations
Ten rough three-dimensional models were constructed using
the academic version 9.7 of MODELLER [19,20] with the default
parameters. The qualities of the models were analysed, and the
best model was chosen for further reﬁnement by MD simulation.
The system energy was minimised with a harmonic constraint
of 100 kJ/mol/Å2 for 5000 steps, including 2500 steps of steepest
descent, followed by 2500 steps of conjugated gradient. After that,
the system was heated from 0 to 300 K. The production simulation
lasted for 6 ns at constant temperature (300 K) and pressure with a
Y. Jia et al. / FEBS Letters 584 (2010) 4789–4796 47911 fs time step. In all of the theoretical simulations, a 10 Å non-
bonded cutoff was used. A PARM03 force ﬁeld was used for the en-
zyme using the Amber9 software package [21].
3. Results
3.1. Absence of propeptide or protease activity blocks the maturation
of NK
Our previous studies have shown that only inactive WT NK was
produced in vivo without the assistance of the propeptide. This re-
sult reveals that the propeptide plays an essential role in guiding
the in vivo folding of the protein to produce active NK. In this
study, the Ser221Ala mutant was produced as in precursor form
even with the help of the propeptide in vivo or by the rapid-dilu-
tion folding technique in vitro, which suggests that the subtilisin
activity is important for the maturation of the precursor. These re-
sults demonstrate the importance of the propeptide and subtilisin
activities for the maturation of NK.
3.2. Three regions show sequence alignment conservation
The alignment of the propeptide sequences of several different
subtilisins revealed that the overall sequence identity is low, but
three regions displayed signiﬁcant sequence conservation (Fig. 1).
Based on the crystal structures of the propeptide–subtilisin com-
plex of subtilisin BPN0 [22] and subtilisin E [23], these conserved
regions fold into b-strands to form a complementary surface that
interacts with the two parallel helices formed by the subtilisin do-
main. Residues in the conserved regions may be critical in the
in vivo folding process because of this direct interaction.
3.3. Mutations in conserved regions of the propeptide result in mutants
produced in vivo that have different secondary structures and kinetic
parameters
It is assumed that hydrogen bonds formed by conserved regions
are important for folding through direct interactions. Thus, we
chose two residues of different levels of conservation to determine
whether the level of importance is consistent with the different
levels of conservation of the residues. In conserved regions of the
propeptide, Gly34 is one of the most conserved residues, while
Ile11 is not as highly conserved as Gly34. At the interface, the hydro-
gen bonding pattern of the side chain may be critical for the direct
interaction. Mutation of Gly34 to Asp dramatically changes the side
chain, while mutation of Ile11 to Val only slightly changes the side
chain. Therefore, we examined whether the conformation and ki-
netic parameters of the Gly34Asp mutant are altered to a greater
extent relative to the WT than those of the Ile11Val mutant.
Although Ile30 is located in a non-conserved region, Ile30Val subtil-Fig. 1. Sequence alignment of propeptides from various subtilisins showing three conser
secondary structures and the mutated residues are indicated.isin E has a different conformation compared than subtilisin E [24].
We chose to mutate Ile30 to Val to determine whether a residue in
a non-conserved region plays an essential role during folding.
Active mutants (Ile11Val, Ile30Val and Gly34Asp) could be pro-
duced in vivo. After puriﬁcation to homogeneity (Fig. 2A), proteins
were analysed by Western blotting (Fig. 2B), and their secondary
structures were analysed using CD (Fig. 2C) and ﬂuorescence stud-
ies (Fig. 2D). Fig. 2C and D show that both the Ile11Val and
Gly34Asp mutants had different secondary structures from that
of WT subtilisin, whereas the secondary structure of Ile30Val was
almost identical to that of WT subtilisin.
3.4. Mutation around the interface of the subtilisin domain blocks
in vivo maturation of the mutant precursor but not in vitro refolding
Maturation of Trp106Tyr and Trp113Tyr mutant precursors was
blocked in vivo even in the presence of propeptide. A rapid-dilution
folding technique was applied to initiate the refolding of both mu-
tant precursors. This in vitro process was monitored by the appear-
ance and disappearance of the two protein bands, one for precursor
and one for mature subtilisin. This process was similar for the two
mutant precursors, and only the results for the Trp106Tyr mutant
precursor are shown (Fig. 3A). Almost 90% of proteins in the solu-
tion were proteolysed by active Trp106Tyr mutant during
refolding.
After analysis by SDS–PAGE (Fig. 3B) and Western blotting
(Fig. 3C), the secondary structures of the Trp106Tyr and Trp113Tyr
mutants were analysed by CD (Fig. 3D) and ﬂuorescence studies
(Fig. 3E). These results show that the secondary structures of these
mutants were different from that of WT subtilisin. As shown in
Table 1, there was a slight decrease in the catalytic efﬁciency
(kcat/Km) of the mutants.
3.5. Construction of a three-dimensional structural model of the
propeptide–subtilisin complex and MD simulations
As shown in Fig. 4A, a three-dimensional structural model of the
propeptide–subtilisin complex was constructed to provide insight
into the interaction between the propeptide and subtilisin do-
mains. The secondary structure of the subtilisin domain consists
of nine b-strands and eight a-helices. The propeptide domain is
made up of four antiparallel b-strands (named b-strands I, II, III
and IV, containing residues Lys8-Lys15, Gly34-Phe41, Asn45-Leu51
and Ser64-Ala74, respectively) and two a-helices (formed by
Ser23-Lys33 and Glu53-Lys60). The interface is shown in Fig. 4B. This
interface is similar to those of subtilisin BPN0 and subtilisin E. At
the interface site, all three structures have some identical hydro-
phobic residues, and the hydrogen bonding pattern is similar
among them. However, several differences were observed around
the active site. In the structure of subtilisin BPN0, Ser221 was 
ved regions. Amino acids in squares represent conserved residues. The ranges of the
A B
DC
Fig. 2. (A) SDS–PAGE analysis of puriﬁedWT subtilisin and mutants. Puriﬁed proteins were applied to a 12% polyacrylamide gel, and after electrophoresis, the gel was stained
with Coomassie Brilliant Blue. Protein standards (in kilodaltons) were applied. (B) Western blotting analysis of puriﬁed WT subtilisin and mutants. Protein standards (in
kilodaltons) were applied. (C) CD spectra of WT subtilisin and mutants. A concentration of 0.1 mg/ml was used for all proteins. (D) Intrinsic ﬂuorescence emission spectra of
the WT subtilisin and mutants. The ﬁnal concentration of each protein was 10 lg/ml, and the excitation wavelength used was 295 nm. The WT subtilisin is represented by a
solid line, Ile11Val is represented by a dotted line, Ile30Val is represented by a dashed and dotted line, and Gly34Asp is represented by a dashed line. Data were collected as
described in Section 2.
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the present structure, Ser221 was not mutated. In addition, residue
76 of the propeptide domain is Ala in subtilisin BPN0, while it is Glu
in subtilisin E and NK. These differences lead to a somewhat al-
tered hydrogen bonding patterns around the active site.
From the structure, it is clear that Trp106 interacts with Gly102,
Tyr104 and Ser105, which in turn form hydrogen bonds with Ala74,
His72 and Asp71 in the IMC domain. When Trp106 is mutated to
Tyr, the lengths of these hydrogen bonds change, and the hydrogen
bond formed by the OG or N of Ser105 and OD2 of Asp71 is broken
(Fig. 5A and B). As shown in Fig. 6A and C, the OG (Ser105)–OD2
(Asp71) distance of WT subtilisin is stable at 3.1 Å after the 2 ns
simulation, and the N (Ser105)–OD2 (Asp71) distance is 3.4 Å.
Fig. 6B and D show that in the Trp106Tyr mutant, the OG
(Ser105)–OD2 (Asp71) and N (Ser105)–OD2 (Asp71) distances in-
crease to 3.8 and 4.6 Å, respectively, which are greater than the
functional hydrogen bond interaction distance. These results sug-
gest that substitution of Trp106 to Tyr breaks both of these hydro-
gen bonds.
4. Discussion
Although NK was analysed as a model, it is likely that similar
mechanisms exist for all subtilisins. Based on the data presentedin this manuscript, we conclude that (i) the propeptide functions
as an IMC mediating the in vivo folding of subtilisin; (ii) two resi-
dues of b-strands formed by conserved regions of the propeptide
are important for the folding of the subtilisin domain through a di-
rect interaction with the subtilisin domain, whereas a residue
belonging to the two a-helices formed by non-conserved segments
is not; (iii) protein memory is observed in vivo; and (iv) some
interfacial change involving conserved regions, even that induced
by the subtilisin domain, could block the in vivo folding and
change the subtilisin conformation.
4.1. Propeptide as an IMC guides the in vivo folding of the precursor
Work conducted in our early studies has shown that removal of
the propeptide results in the production of misfolded, inactive pro-
tease [13]. Furthermore, the absence of protease activity blocks the
maturation of the precursor, which implies that cleavage of the
propeptide is mediated by the catalytic triad Asp32, His64 and
Ser221. Although the propeptide is removed after the maturation
of NK, Fig. 2C and D show that mutants (Ile11Val and Gly34Asp)
andWT subtilisin have different secondary structures and different
kinetic parameters (Table 1). These results reveal that there is an
interaction between the propeptide and subtilisin domains and




Fig. 3. (A) In vitro refolding of Trp106Tyr precursor. Precursor was refolded by rapid dilution. Aliquots (350 ll) were removed at ﬁxed time intervals and treated with an
equal volume of 40% trichloroacetic acid to stop the reaction. After protein precipitation, the protein pellets were dissolved in SDS loading buffer. (B) SDS–PAGE analysis of
puriﬁed WT subtilisin and mutants. Puriﬁed proteins were applied to a 12% polyacrylamide gel, and after electrophoresis, the gel was stained with Coomassie Brilliant Blue.
Protein standards (in kilodaltons) were applied. (C) Western blotting analysis of puriﬁed WT subtilisin and mutants. Protein standards (in kilodaltons) were applied. (D) CD
spectra of WT subtilisin and mutants. A concentration of 0.1 mg/ml was used for all proteins. (E) Intrinsic ﬂuorescence emission spectra of the WT subtilisin and mutants. The
ﬁnal concentration of each protein was 10 lg/ml, and the excitation wavelength used was 295 nm. WT subtilisin is represented by a solid line, Trp106Tyr is represented by a
dashed line, and Trp113Tyr is represented by a dotted line. Data were collected as described under in Section 2.
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tion is in accordance with the results for the Trp106Tyr and
Trp113Tyr mutants. Mutation of Trp106 to Tyr and Trp113 to Tyr
blocked in vivo maturation of the precursor. After in vitro refolding
by rapid dilution (Fig. 3A), both mutants displayed a slight de-
crease in the catalytic efﬁciency (Table 1). This slight decrease in
the catalytic efﬁciency is clearly not the reason for the production
of mutant precursor. Therefore, the production of mutant precur-
sor is due to conformational changes occurring at the interface,
which are induced by the substitution of Trp106 and Trp113. These
results demonstrate that the interaction between the propeptide
and subtilisin domains is essential for in vivo folding. These data,
together with the studies by Inouye and co-workers [4,5], signify
that the propeptide of subtilisin functions as an IMC mediating
the in vivo folding of the precursor.4.2. Conserved regions of propeptide fold into three b-strands that may
be essential for in vivo folding
Alignment of the sequences of propeptides from the subtilisin
family revealed that the overall sequence identity is low but that
three regions showed signiﬁcant sequence conservation. Gly34 is
an identical among these different propeptides and is located in
homologous regions. Ile11 is also in a conserved region, but it is
not as conserved as Gly34. Ile30 is in a non-conserved segment.
Among these three mutants, the Gly34Asp mutant has the confor-
mation that is the most different from that of the WT subtilisin and
has the lowest kinetic parameters. Next is Ile11Val mutant,
whereas the secondary structure and kinetic parameters of the
Ile30Val mutant were with the same as those of WT subtilisin.
These results indicate that the hydrogen bonds formed by the
Fig. 4. A three-dimensional structural model of the propeptide–subtilisin complex. (A) The ribbon and tube structure of the complex in which the a-helices are displayed in
red, the b-strands are in yellow, and loop regions are in light cyan. (B) The interface between the propeptide and subtilisin domains. Two a-helices on the surface of the
subtilisin domain and four antiparallel b-strands from the propeptide domain contribute to this interface. The subtilisin domain is displayed in blue. In the propeptide
domain, b-strand I, II and IV, which are belong to the conserved regions, are in pink, b-strand III is in green, and the two a-helices apart from the interface are in light cyan.
Fig. 5. (A) The hydrogen bonding interactions around Trp106 of WT subtilisin. (B) The hydrogen bonding interactions around Tyr106 of the Trp106Tyr mutant. Around the
106-position amino acid, Gly102, Tyr104 and Ser105 form hydrogen bonds with Ala74, His72 and Asp71 of the propeptide domain, respectively. The residues are displayed in
standard atomic colours and are labelled by residue name.
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in vivo folding of the precursor. It is interesting that the level of
importance is consistent with the different levels of conservation
of the residues. These results are in accordance with the
three-dimensional structural model of the propeptide–subtilisin
complex. As shown in Fig. 4B, b-strands I, II and IV are in the three
conserved segments (residues Tyr10-Lys15, Gly34-Ala46 and
Leu59-Asp71) of the propeptide, while b-strand III and two a-helices
are in the non-conserved regions. There are many hydrogen bonds
between these four b-strands, which are on the surface of the pro-
peptide domain and form the site of interaction with the subtilisin
domain, whereas the two a-helices are not part of the interface and
form almost no hydrogen bond with these b-strands. We speculate
that b-strands I, II and IV are critical for the nucleation of the fold-
ing process, whereas b-strand III is crucial for speciﬁc interactions
with their cognate subtilisin domains. The two a-helices formed by
non-conserved segments are not critical.
The different conformation and the slight decrease in the cata-
lytic efﬁciency reveal that substitution of Ile11 and Gly34 alters the
secondary structure but does not signiﬁcantly affect the catalytic
triad. Therefore, both amino acids are believed to participate in
hydrogen bond formation with residues around the catalytic triadexcept for His32, Asp64 and Ser221. This assumption is consistent
with the three-dimensional structural model that Ile11 and Gly34,
in b-strand I and b-strand II, respectively, interact with several
amino acids of the subtilisin domain, whereas the end of b-strand
IV extends into the subtilisin domain and binds the active sites. The
slight decrease in the catalytic efﬁciency was due to the conforma-
tional changes caused by these residues because the involved res-
idues affect other parts of the protein. Similar structural alterations
may affect the surface charge distribution in subtilisin, which can
alter its enzymatic properties [25].
4.3. The protein memory phenomenon exists in vivo
A phenomenon called protein memory, in which a protease can
fold into different conformations during in vitro refolding, was pre-
viously observed by Inouye and co-workers [24]. Conformational
diversity within unique amino-acid sequences is observed in dis-
eases such as scrapie and Alzheimer’s, which occur in vivo. Here,
the Ile11Val and Gly34Asp mutants and WT subtilisin have identi-
cal amino-acid sequences. They also have different secondary
structures and kinetic parameters. Our studies indicate that an
identical protease can also fold into different conformations
A B
DC
Fig. 6. (A) The distance trajectories between OG (Ser105) and OD2 (Asp71) for WT subtilisin. (B) The distance trajectories between OG (Ser105) and OD2 (Asp71) for the
Trp106Tyr mutant. (C) The distance trajectories between N (Ser105) and OD2 (Asp71) for WT subtilisin. (D) The distance trajectories between N (Ser105) and OD2 (Asp71) for the
Trp106Tyr mutant.
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subsequent change in the kinetic parameters of the protease,
which may lead to some disorders during life process.
4.4. Some interfacial change involving conserved regions induced by
the subtilisin domain could block the in vivo folding and could change
the subtilisin conformation
Mutation of Trp106 to Tyr and Trp113 to Tyr did not block the
in vitro refolding of the precursor but blocked the in vivo matu-
ration of the precursor. This result is similar to those of studies
on subtilisin E, which showed that the substitution of Trp106
with Tyr or of Trp113 with Tyr drastically altered the autonomic
behaviour of the IMC and the process of protein folding [26].
Based on the three-dimensional structural model and MD stimu-
lations, although neither Trp106 nor Trp113 interacts directly with
the IMC, they both make contacts with interfacial amino acid
residues that form part of the interface between the two do-
mains. For example, Trp106 interacts with Ser105, which in turn
forms two hydrogen bonds with Asp71 of the IMC domain. Sub-
stitution of Trp106 with Tyr breaks the hydrogen bonds formedby the OG or N of Ser105 and OD2 of Asp71. Simultaneously,
Asp71 is involved in the formation of b-strand IV, which forms
part of the conserved regions of the propeptide, and the hydro-
gen bonds formed by b-strand IV are critical for precursor fold-
ing. The removal of this hydrogen bond disturbs interfacial
interactions between the two domains. This result is partly con-
sistent with the CD difference spectra, which indicated that
some interfacial change involving the conserved regions, even
the change induced by the subtilisin domain, would lead to a
different subtilisin conformation and would block precursor
maturation.
4.5. Protein folding in vivo differs from precursor refolding in vitro
The results concerning the Trp106Tyr and Trp113Tyr mutants
suggest that protein folding in vivo and precursor refolding
in vitro are different. This conclusion is in agreement with that of
a study concerning subtilisin BPN0 completed by Wells and co-
workers [14]. The different conditions for protein folding in vivo
and precursor refolding in vitro led to different CD spectra for
WT subtilisin and both Tyr mutants.
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